News Archive
CII Award
PharmaZell (India) Private Limited, Vishakhapatnam has been awarded second place in the category of Industrial Best Process Safety Practices by CII Andhra Pradesh Industrial Safety Excellence Awards 2021. PIPL Vizag...
Teriflunomide – API and Licensing Agreements for Tablets available
PharmaZell Group is pleased to announce that the US Food and Drug Administration has granted approval of Breckenridge Pharmaceutical, Inc. Abbreviated New Drug Application for Teriflunomide 7mg & 14mg Tablets...
FarmaBios – Update on constructions at Gropello Cairoli (Italy)
Moving forward in plan. Reactors and Centrifuges are in place...
Pharma Zell(India) Private Limited awarded EcoVadis Silver Medal in Recognition for Sustainability Performance
We are pleased to announce that PharmaZell(India)Private Limited has been awarded EcoVadis Silver Medal in Recognition for Sustainability Performance. This Recognition places our company among the top 25 percent of...
Update on 5-ASA New Project in Vizag (India)
New expansion of fully automated and dedicated Production facility for Mesalamine has picked up its momentum at Visakhapatnam site. It is targeted to start the production in October-2021. Impact of...
EU validates Farmabios Cannabidiol (CBD) Ingredient for Novel Food
20 April 2021, the PharmaZell Group one on Europe’s leading manufacturer of active ingredients, is pleased to announce its production site FarmaBios SpA (in Gropello/Italy) has received validation from the...
CEO speaks at 25th Anniversary of PharmaZell plant in Chennai
Despite all restrictions and taking into account the COVID regulations, CEO Dr. Bolzern did not miss the opportunity to attend the celebration of the 25th anniversary of the PharmaZell Group...
CEO Appreciating COVID Warriors
CEO Dr. Oliver Bolzern visited the Visakhapatnam site in February. He appreciated the various measures and efforts taken during COVID pandemic which has helped to restrict any potential disturbance in...
PharmaZell – Update on new Mesalazine production building in Vizag (India)
We are pleased to share the last update on the construction of the new production building. The construction works are on schedule, three levels are already completed as shells. Looking...
New PharmaZell Trainees in Raubling /Germany
In September seven young employees started their traineeship at the PharmaZell site Raubling (Germany). As one of their first joint activities they elected their new youth and trainee representative (JAV...
Novel Food Ingredient registration – synthetic CBD
We are pleased to announce that the activities on synthetic CBD at our Farmabios site are progressing smoothly. The API is produced at a commercial batch size using a THC-free...
Private Equity owner Bridgepoint visits PharmaZell Group’s company Farmabios
In October 2020 our new investor Bridgepoint visited the Farmabios site in Gropello-Cairolli (Italy). Besides holding its regular board meeting, the attendees went on an extensive plant tour. They were...
FarmaBios – Update on construction of new steroid building in Gropello Cairoli (Italy)
The construction of the new steroid building is even in Covid-19 times running smoothly and almost on schedule. The department would have three layers for 980 m3 total with a...
New ISO Certificates for FarmaBios (Gropello Cairoli, Italy)
FarmaBios successfully completed the certification process in accordance with the ISO 45001:2018 standards. The new certificate is the last achievement of the list together with ISO 9001:2015 and ISO 14001:2015....
FarmaBios – Update on new warehouse in Gropello Cairoli (Italy)
We are pleased to share the last updates on our new warehouse building, indeed the works are on schedule: the first storage racks have been already installed. The warehouse would...
PharmaZell (India) Private Limited. – Vizag
Vizag Unit has got approval from Board to expand 5ASA for one more separate 180 TPA manufacturing facility. Site clearance is given and the Civil work inaugural was organised on...
We are very glad to announce that AIFA renewed the complete GMP certificate for Farmabios on July 7th 2020 SpA facility
We are very glad to announce that AIFA renewed the complete GMP certificate for Farmabios on July 7th 2020 SpA facility
Farmabios expands its Manufacturing Footprint in Gropello Cairoli (Italy)
The construction of a brand new large steroid building and a new warehouse on the Farmabios premises in Gropello Cairoli (Italy) is moving forward nearly in plan. After construction work...
Acquisition of PharmaZell Group by Bridgepoint completed. PharmaChol fully owned by the PharmaZell Group.
Bridgepoint, an international asset management firm with over €20 billion of assets, announced the acquisition of the PharmaZell Group in February 2020. After obtaining all necessary authorizations, we are very...
CURRENT COVID-19 OUTBREAK: SUPPORTIVE HELP
Farmabios is pleased to announce that it has just finalized the production and distribution of sanitizing gels to Covid-19 task forces and structures which are serving the neighboring area, as...
UPDATE 4: IMPACT OF THE CURRENT COVID-19 OUTBREAK ON INDIAN PRODUCTION SITES
PharmaZell Group is very conscious of our important role and duty in delivering APIs to our customers and being an active part in maintaining the health system running. Up to...
FarmaBios activities are regularly proceeding…
During this critical and challenging period, Farmabios SpA states that our activities are regularly proceeding. We are conscious of the role and duty in delivering APIs, and our active part...
Breaking News: PharmaZell Group acquired by Bridgepoint
The PharmaZell Group management is very pleased to inform that the Group was acquired by Bridgepoint from DPE Deutsche Private Equity and Maxburg Capital Partners for an undisclosed sum. Bridgepoint...
Farmabios Breaks Ground to Expand its Manufacturing Footprint in Gropello Cairoli (Italy)
As part of an ongoing investment program to enhance PharmaZell Group’s production output, we have initiated the construction of a brand new large steroid building and a new warehouse on...
Renewed GMP Certificate for our Manufacturing Facility Farmabios in Gropello Cairoli (Italy)
We are very glad to announce that the competent Italian authority (AIFA) has issued a renewed GMP certificate for our Farmabios SpA production facility [http://eudragmdp.ema.europa.eu/inspections/gmpc/generateGMPCPDF.do].
Farmabios expands its portfolio with Cannabidiol API
Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios...
